National Institute for Health and Care Excellence (NICE)

Search within:  
Sort results by:      



1-20 of 220   Next >
 
2.  
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis. 2015 Dec 16. NGC:010878
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
3.  
Acute heart failure: diagnosing and managing acute heart failure in adults. 2014 Oct. NGC:010568
National Clinical Guideline Centre - National Government Agency [Non-U.S.].
4.  
Acute kidney injury. Prevention, detection and management of acute kidney injury up to the point of renal replacement therapy. 2013 Aug. NGC:010009
National Clinical Guideline Centre - National Government Agency [Non-U.S.].
5.  
Acute upper gastrointestinal bleeding: management. 2012 Jun (reaffirmed 2014). NGC:009131
National Clinical Guideline Centre - National Government Agency [Non-U.S.].
6.  
7.  
Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System. 2012 Aug. NGC:010544
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
8.  
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer. 2014 Apr. NGC:010348
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
9.  
Aflibercept for treating diabetic macular oedema. 2015 Jul. NGC:010771
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
10.  
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. 2014 Feb. NGC:010285
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
11.  
12.  
Aflibercept solution for injection for treating wet age-related macular degeneration. 2013 Jul. NGC:009971
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
13.  
Alcohol-use disorders. Diagnosis, assessment and management of harmful drinking and alcohol dependence. 2011 Feb. NGC:008761
National Collaborating Centre for Mental Health - National Government Agency [Non-U.S.].
14.  
Alemtuzumab for treating relapsing–remitting multiple sclerosis. 2014 May. NGC:010430
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
15.  
Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122). 2007 Jun (revised 2012 Sep). NGC:009332
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
16.  
Anaemia management in people with chronic kidney disease. 2006 (revised 2015 Jun 3). NGC:010726
National Clinical Guideline Centre - National Government Agency [Non-U.S.].
17.  
Anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode. 2011 Dec. NGC:009030
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
18.  
Antibiotics for early-onset neonatal infection. Antibiotics for the prevention and treatment of early-onset neonatal infection. 2012 Aug. NGC:009307
National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.].
19.  
Antisocial behaviour and conduct disorders in children and young people: recognition, intervention and management. 2006 Jul (revised 2013 Mar). NGC:009747
National Collaborating Centre for Mental Health - National Government Agency [Non-U.S.]; Social Care Institute for Excellence (SCIE) - Nonprofit Research Organization.
20.  
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation. 2013 Feb. NGC:009629
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.].
1-20 of 220   Next >